Format

Send to

Choose Destination
See comment in PubMed Commons below
Am J Kidney Dis. 2013 Apr;61(4):555-63. doi: 10.1053/j.ajkd.2012.11.033. Epub 2012 Dec 20.

Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: the Osteoporotic Fractures in Men (MrOS) Study.

Author information

1
Division of Nephrology and Hypertension, Department of Medicine, University of California San Diego, San Diego, CA 92161, USA.

Abstract

BACKGROUND:

Serum phosphorus is associated with cardiovascular disease (CVD) in the general population, but may not comprehensively reflect phosphorus homeostasis. Whether urine phosphorus-creatinine ratio (a marker of intestinal absorption) or urine fractional excretion of phosphorus (FEPi; a marker of urinary phosphorus handling) is associated with risk of mortality or CVD is uncertain.

STUDY DESIGN:

Prospective observational study.

SETTING & PARTICIPANTS:

1,325 community-dwelling men 65 years or older participating in the MrOS Study.

PREDICTOR:

Serum phosphorus, urine phosphorus-creatinine ratio, and FEPi.

OUTCOMES:

All-cause and CVD death.

RESULTS:

Mean age was 74 ± 6 (SD) years, estimated glomerular filtration rate was 75 ± 16 mL/min/1.73 m(2), and serum phosphorus level was 3.2 ± 0.4 mg/dL. During a median follow-up of 9.3 years, there were 364 (120 CVD) deaths. After adjustment for demographics, CVD risk factors, and kidney function, the risks of all-cause death in the highest quartiles of serum phosphorus (≥3.6 mg/dL), urine phosphorus-creatinine ratio (≥0.55), and FEPi (≥18%) were 1.63 (95% CI, 1.23-2.17), 1.22 (95% CI, 0.90-1.65), and 0.88 (95% CI, 0.64-1.23), respectively, compared to the lowest quartiles of each. Results were similar for CVD death. Results also were similar in those with estimated glomerular filtration rate ≥60 and <60 mL/min/1.73 m(2).

LIMITATIONS:

Older all-male cohort. Few had advanced chronic kidney disease. Spot urine specimens were used.

CONCLUSIONS:

In community-living older men, higher serum phosphorus concentrations are associated with all-cause and CVD death. In contrast, urine phosphorus-creatinine ratio and FEPi are not. These findings do not support using urine phosphorus-creatinine ratio or FEPi as adjuvant measures to predict risk of mortality or CVD in the general population.

PMID:
23261120
PMCID:
PMC3815620
DOI:
10.1053/j.ajkd.2012.11.033
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center